Tudor I. Oprea
Pharmacology · 1999–2021
A researcher in the Science corpus: 16 papers; trusts 2 researchers and is trusted by 14 researchers here, as inferred from the citation graph.
Subfields
- Pharmacology — 47 citations into it
- Spectroscopy — 27 citations into it; #535 of 1,674 by trust here, #494 by citations
- Oncology — 18 citations into it
Whom Tudor I. Oprea trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Tudor I. Oprea overall
- I. Kapetanovic
- W. Patrick Walters
- Alexandru Korotcov
- Jürgen Bajorath
- Peter Willett
- Nicholas E. Thomford
- Philip J. Hajduk
- M. Pettersson
- Christopher A. Lipinski
- Sean Ekins
Papers from Tudor I. Oprea's perspective
Ordered by how strongly the researchers Tudor I. Oprea trusts endorse each paper. Same corpus, a different order for every researcher.
- The druggable genome (Nature reviews. Drug discovery)
- DrugBank 4.0: shedding new light on drug metabolism
- The ChEMBL bioactivity database: an update
- Ultra-large library docking for discovering new chemotypes (Nature)
- Drugs, their targets and the nature and number of drug targets (Nature reviews. Drug discovery)
- Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.
- Highly accurate protein structure prediction with AlphaFold
- How many drug targets are there?
- SuperTarget and Matador: resources for exploring drug-target relationships (Nucleic Acids Res.)
- From genomics to chemical genomics: new developments in KEGG (Nucleic Acids Res.)
Their papers
- Is There a Difference between Leads and Drugs? A Historical Perspective (2001) — 675 citations
- A comprehensive map of molecular drug targets (2016) — 2,065 citations
- Integrating virtual screening in lead discovery. (2004) — 240 citations
- QSAR without borders (2020) — 546 citations
- ChemProt: a disease chemical biology database (2010) — 121 citations
- Virtual and biomolecular screening converge on a selective agonist for GPR30 (2006) — 832 citations
- ChemProt-3.0: a global chemical biology diseases mapping (2016) — 168 citations
- Property distribution of drug-related chemical databases* (2000) — 564 citations
- WOMBAT: World of Molecular Bioactivity (2005) — 121 citations
- CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding (2021) — 83 citations
- Faculty Opinions recommendation of Structural basis of PROTAC cooperative recognition for selective protein degradation. (2017) — 444 citations
- BDDCS, the Rule of 5 and Drugability (2016) — 757 citations
- Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients (2014) — 402 citations
- BDDCS Applied to Over 900 Drugs (2011) — 611 citations
- Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. (2008) — 624 citations
- The Design of Leadlike Combinatorial Libraries. (1999)